Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences

from Mendelspod Podcast · host Theral Timpson

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 Novel Cas enzymes help overcome CRISPR challenges11:37 New pipeline of therapies will go after novel targets14:52 How does the new platform open up possibilities for new diagnostics?21:05 What risks do you think about?26:47 What are the company’s two-year goals?31:07 On the possibilitiesCRISPR technology is enabling a new generation …

Episode metadata supplied by the publisher feed · Published Sep 5, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences

0:00 6:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mendelspod Podcast?

This episode is 6 minutes long.

When was this Mendelspod Podcast episode published?

This episode was published on September 5, 2023.

Can I download this Mendelspod Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!